Treatment with the anticonvulsant drug phenytoin results in clinically apparent gingival hyperplasia, and thus poses a treatment problem for dental practitioners. Phenytoin gingival hyperplasia seems to exhibit a marginal preference for males.
The cytoplasm of normal male and female gingiva contains a receptor capable of specifically binding 5a-DHT with high affinity and low capacity. It is extremely heat-sensitive and exhibits a pattern of competition similar to that obtained with 5a-DHT receptors from other target tissues. This demonstration of a specific Sa-DHT receptor in human gingiva provides the first direct biochemical evidence that this tissue may act as a target organ for androgens (Southren et al., 1978) . An increased number of receptors for Sa-DHT has been located in gingival cells actively metabolizing testosterone (Vittek et al., 1976 (Vittek et al., , 1982 . There is a 2-3-fold increase in concentration of 5a-DHT in hyperplastic gingiva (caused by drugs or seen in pregnancy) as compared with normal tissue.
In microsomal preparations from periodontal membranes, testosterone can be metabolized mainly to Sa-DHT, the principal biologically active metabolite in influencing cell proliferation and collagen biosynthesis. In similar preparations from inflamed gingiva from human subjects of both sexes, however, the metabolic activity is higher than in healthy gingiva (Ojanotko et al., 1980) . In the male preparations there was an approximately 3-fold increase in metabolism compared with the females. Most of the healthy female samples seemed not to metabolize testosterone at all. However, the metabolism of the inflamed preparations in both sexes appears to be of the same magnitude.
Abbreviation used : Sa-DHT, Sa-dihydrotestosterone.
The aim of the present study was to investigate the possibility of enhanced testosterone metabolism by human gingival fibroblasts in culture in the presence of phenytoin or its metabolites and hence to determine the role of biologically active androgens in stimulating fibroblast proliferation and collagen biosynthesis, which results in the clinically apparent phenytoin gingival hyperplasia.
The source of human gingival fibroblasts was connective tissue from the third molar region. The tissue was finely minced and distributed in angled neck flasks with Eagle's minimum essential medium (1 ml), supplemented with 10% tbetal calf serum (MEM + FCS). When the primary cell line was confluent, serial passaging was carried out as follows. The primary cell line was trypsinized and the cell aggregates were separated by passing them through finely drawn capillary tubes. They were redistributed in angled neck tissue culture flasks with MEM + FCS (4ml), and incubated in a C 0 2 humidity incubator.
Monolayer cultures between the fifth and ninth passage were trypsinized and cell counts made in a haemocytometer.
Appropriate dilutions were made with MEM + FCS and the cells were plated at a density of 50000 cells/well in multiwell plates; incubation was for 24 h. Unlabelled testosterone was added as substrate at concentrations of lo-*, lo-' or 10-6mol/ml along each row. There were two control rows: one without cells and one with cells but with no substrate.
The reaction was terminated by the addition of ethyl acetate (2ml). Unlabelled carrier steroids (IOOpg each), corresponding to the anticipated metabolites, were added to each sample and extraction performed with ethyl acetate (3 x 2ml). Extracted metabolites and carrier steroids were subjected to t.1.c. in benzene/acetone (4 : 1, v/v), run once. The metabolites were tentatively identified against standards, run alongside, using radiochromatogram scanning, and autoradiography as described by Cooke & Gower (1 977).
After elution from the thin-layer plate the metabolites were quantified by scintillation counting. Gas-liquid chromatography was used to estimate the mass of carrier steroids, thus allowing corrections to be made for analytical losses of the radioactive metabolites (Cooke & Gower, 1977 The odorous boar pheromone 5a-androstenone has been quantified in axillary secretions of men and women (Claus & Alsing, 1976; Bird & Gower, 1981) . Pure apocrine secretions are odourless until incubated with certain bacteria (Shehadeh & Kligman, 1963) , and a coryneformdominated axillary microflora is associated with pronounced axillary odour (Jackman & Noble, 1982) . The possibility that Sa-androstenone is formed by microbial action was shown by Bird & Cower (1982), using a general germicidal agent, and it seems likely that an odourless precursor is secreted in apocrine sweat and then modified microbially.
In the present work we have studied the metabolism of some putative steroid precursors of 5a-androstenone by cultures of human axillary bacteria. Pregnenolone was tested first because of its role as a precursor of 16-androstenes in porcine testis (Cower, 1981 ; Booth, 1982) and then testosterone and 5a-DHT because of the possibility of microbial dehydration at C-16 and C-17 to form 16-androstenes.
Two coryneform bacteria were used in this study; one (identification code L 163M) has been described previously (Jackman, 1982) , the other (identification code 1L1) was isolated from one of the authors at the start of this study.
The bacteria were inoculated into 'coryneform Broth', a modification of TY agar (Pitcher, 1983) without the agar, and with 0.5% (v/v), rather than 0.2% (v/v), Tween 80. To this was added 0.5ml of 14C-labelled steroid solution (2mg, 2Ci/ml in redistilled ethanol). Preliminary work had indicated that significant yields of metabolites took 2-3 weeks to form at 37"C, and so 3-week cultures were used Abbreviations used : 5a-androstenone, 5a-androst-16-en-3-one ; 5a-DHT, Sa-dihydrotestosterone; MO-TMS, methyloxime-trimethyl silyl ether; 5B-androstenone, 5Fandrost-16-en-3-one. throughout this work. In all cases, controls, set up as above but without the bacteria, were run in parallel with the test cultures.
The cultures (and controls) were extracted with redistilled ethyl acetate (3 x 5ml) and the Na2S04-dried extracts were evaporated in a Buchler Vortex-Evaporator at 20°C before spotting on t.1.c. plates (20cm x 20cm, 0.2mm thickness; Kieselgel 60, Merck, Darmstadt). Pregnenolone metabolites were developed by running twice in benzene/acetone (8 : 1, v/v), while testosterone and 5a-DHT extracts were run once in benzenelmethanol(9 : 1, v/v) followed by a second run in benzene/acetone (6 : 1, v/v). Radiolabelled metabolites were located by autoradiography and examined by capillary g.c. and g.c.-m.s. The former was performed using a Pye-Unicam 104 gas chromatograph with a SGE BPI fused silica column (25m x 0.33mm, with helium as carrier gas and argon as make up gas). G.c.-m.s. was performed using a V. G . Analytical Ltd Model 305 mass spectrometer-2025 data system (source conditions: Electron impact; 500pA trap current, 40eV ionization potential; 4kV accelerating voltage). A Pye-Unicam 204 gas chromatograph, with a SE-30 quartz capillary column (25mx 0.32mm, run at 250°C with 55 kPa helium as carrier gas), was directly interfaced to the mass spectrometer source. Radiolabelled metabolites were identified where possible by the gas chromatographic behaviour and mass spectra of their underivatized and MO-TMS derivatives compared with those of standards (obtained either commercially or as gifts from the MRC steroid reference collection).
5b-Androstenone was synthesized from 5/3-androst-16-en-3a-01 by chromic acid oxidation (Bush, 1961) . This and 5a-androstenone were spotted on t.1.c. plates and run in dichloromethane/ethyl acetate (95 : 5, v/v) (Bird & Cower, 1981) .
So far there is evidence for two metabolites of pregnenolone. One of these was found in trace amounts, and so was not conclusively identified, but had a similar g.c. retention time and underivatized mass spectrum to 17a-hydroxypregnenolone. The second compound was more abundant, and had a g.c. retention time identical to that for Sa-DHT, both underivatized and as the MO-TMS derivative. The mass spectra were also consistent with this identification of the metabolite.
